In the United States and worldwide, public awareness of the progressive rise in antibiotic resistance has increased among public health officials, the medical community, and the lay public. The common use of systemic antibiotic therapy in dermatology warrants a closer look at how prescribing patterns impact on the development of antibiotic resistant bacteria and outcomes in clinical practice.